NCT07349641 2026-03-17
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
Clinical Trials
8 trialsNCT07462663 2026-03-10
SHAPE-ENDO
Hospital Universitari de Bellvitge
Not yet recruiting
NCT07436793 2026-02-27
Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial
New Mexico Cancer Research Alliance
Phase 2 Not yet recruiting
NCT07377734 2026-01-30
A Multicenter, Randomized, Open-Label, Controlled Clinical Trial of Intrauterine Injection of Recombinant Humanized Type III Collage in the Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
Peking University People's Hospital
Phase 2 Not yet recruiting
NCT07078838 2026-01-16
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT07298707 2025-12-23
EndoMethy-V
Peking Union Medical College Hospital
Not yet recruiting
NCT07028242 2025-06-19
ULTRA-SAFE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting
NCT06745427 2024-12-20
PreFerEC/EIN
Region Stockholm
Not yet recruiting